Interview: Applying the science

Published: 7-Nov-2013

Giulio Cerroni is Managing Director of LGC Genomics, a division of the LGC Group that delivers services and products for DNA and genetic analysis, as well as sample preparation. He talked to Susan Birks about genomics, disruptive technology and new pharmaceutical markets

You need to be a subscriber to read this article.
Click here to find out more.

Whether it is for screening newborns for cystic fibrosis, or for helping forensic teams screen and prioritise samples for DNA analysis, or enabling farmers to evaluate whether crops in the field are worth harvesting, Giulio Cerroni, MD of LGC Genomics is excited to see how the science he studied at university is now being successfully applied by industry.

Based in the UK, LGC is an international leader in the supply of laboratory services, measurement standards, reference materials and genomics products and services. Customers include the public sector (forensic, government institutions and universities) and pharma – one of the biggest industrial users of its standards and reference materials.

‘In the genomics sector, we are providing both products and services to the pharmaceutical industry as well as the agri-bio and other sectors.’ Genomics is a relatively young sector that has developed rapidly over the past few decades and much of the recent academic research is now being applied; for example, molecular tests are being used in the agri-bio sector, veterinary practice and in clinical settings.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like